IS1999B - 4-Aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine having neuromuscular and neurotransmitter activity - Google Patents
4-Aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine having neuromuscular and neurotransmitter activityInfo
- Publication number
- IS1999B IS1999B IS4641A IS4641A IS1999B IS 1999 B IS1999 B IS 1999B IS 4641 A IS4641 A IS 4641A IS 4641 A IS4641 A IS 4641A IS 1999 B IS1999 B IS 1999B
- Authority
- IS
- Iceland
- Prior art keywords
- alkyl
- tetrahydropyridine
- aryl
- phenylalkyl
- neuromuscular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
4-Aryl-1-phenyl alkyl-1,2,3,6-tetrahydropyridine derivs. of formula (I), their salts, solvates and quat. ammonium salts are new. Y = CH or N; R1 = H, halo, CF3, 3-4C alkyl or 1-4C alkoxy; R2 = as R1 or OH; R3, R4 = H or 1-3C alkyl; X = 3-6C alkyl, 3-6C alkoxy, 3-7C carboxyalkyl, (1-4C) alkoxycarbonyl(3-6C)alkyl, 3-7C carboxyalkoxy or (1-4C)alkoxycarbonyl(3-6C)alkoxy; or 3-7C cycloalkyl, 3-7C cycloalkoxy, (3-7C)cycloalkylmethyl, 3-7C cycloalkylamino or cyclohexenyl (all opt. substd.); or phenyl, phenoxy, phenylamino, N-(1-3C)alkylphenylamino, phenylmethyl, phenylethyl, phenylcarbonyl, phenylthio, phenylsulphonyl, phenylsulphinyl or styryl (all opt. substd.)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9507760A FR2736053B1 (en) | 1995-06-28 | 1995-06-28 | NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES |
PCT/FR1996/000995 WO1997001536A1 (en) | 1995-06-28 | 1996-06-26 | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
Publications (2)
Publication Number | Publication Date |
---|---|
IS4641A IS4641A (en) | 1997-12-23 |
IS1999B true IS1999B (en) | 2005-04-15 |
Family
ID=9480466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS4641A IS1999B (en) | 1995-06-28 | 1997-12-23 | 4-Aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine having neuromuscular and neurotransmitter activity |
Country Status (30)
Country | Link |
---|---|
US (1) | US5981754A (en) |
EP (2) | EP1216996A3 (en) |
JP (2) | JP3147906B2 (en) |
KR (1) | KR100460581B1 (en) |
CN (1) | CN1153765C (en) |
AT (1) | ATE223897T1 (en) |
AU (1) | AU715090B2 (en) |
BR (1) | BR9608662A (en) |
CA (1) | CA2225746C (en) |
CY (1) | CY2312B1 (en) |
CZ (1) | CZ291075B6 (en) |
DE (1) | DE69623631T2 (en) |
DK (1) | DK0837848T3 (en) |
EE (1) | EE03870B1 (en) |
ES (1) | ES2183965T3 (en) |
FR (1) | FR2736053B1 (en) |
HK (1) | HK1014952A1 (en) |
HU (1) | HUP9900055A3 (en) |
IL (1) | IL122159A (en) |
IS (1) | IS1999B (en) |
NO (1) | NO310144B1 (en) |
NZ (1) | NZ312723A (en) |
PL (2) | PL187087B1 (en) |
PT (1) | PT837848E (en) |
RU (1) | RU2163237C2 (en) |
SK (2) | SK285433B6 (en) |
TR (1) | TR199701710T1 (en) |
UA (1) | UA62914C2 (en) |
WO (1) | WO1997001536A1 (en) |
ZA (1) | ZA965527B (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2762514B1 (en) | 1997-04-29 | 1999-10-22 | Sanofi Sa | USE OF TETRAHYDROPYRIDINE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES LEADING TO DEMYELINATION |
FR2763847B1 (en) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MANUFACTURING TGF-BETA-1 MEDICAMENTS |
FR2771006B1 (en) * | 1997-11-14 | 2000-12-01 | Sanofi Sa | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
FR2771007B1 (en) * | 1997-11-14 | 2000-12-01 | Sanofi Sa | COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE |
CO4980891A1 (en) * | 1997-11-14 | 2000-11-27 | Sanofi Sa | ASSOCIATION OF ACTIVE PRINCIPLES FOR THE TREATMENT OF SENILE DEMENTIA OF THE AZHEIMER TYPE |
JP2002518386A (en) * | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | Production of heteroaryl compounds |
FR2803593B1 (en) * | 2000-01-06 | 2002-02-15 | Sanofi Synthelabo | NOVEL TETRAHYDROPYRIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2823748B1 (en) * | 2001-04-20 | 2004-02-20 | Sanofi Synthelabo | TETRAHYDROPYRIDYL-ALKYL-BENZODIAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO2002085888A1 (en) * | 2001-04-20 | 2002-10-31 | Sanofi-Synthelabo | Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
FR2840896B1 (en) * | 2002-06-18 | 2005-04-08 | Sanofi Synthelabo | PHENYL AND PYRIDYL PIPERAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
BR0316785A (en) * | 2002-12-16 | 2005-10-25 | Mitsubishi Pharma Corp | 4-Pyrimidone-3-substituted derivatives |
JP4866610B2 (en) | 2003-08-18 | 2012-02-01 | 富士フイルムファインケミカルズ株式会社 | Pyridyltetrahydropyridines and pyridylpiperidines |
TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
EA200700117A1 (en) * | 2004-06-24 | 2007-06-29 | Инсайт Корпорейшн | N-SUBSTITUTED PIPERIDINES AND THEIR APPLICATION AS PHARMACEUTICAL PREPARATIONS |
US20060009491A1 (en) * | 2004-06-24 | 2006-01-12 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
JP2008504274A (en) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | Amide compounds and their use as pharmaceuticals |
JP2008504280A (en) | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | 2-methylpropanamide and its pharmaceutical use |
MXPA06014572A (en) * | 2004-06-24 | 2007-03-12 | Incyte Corp | Amido compounds and their use as pharmaceuticals. |
KR20070050076A (en) * | 2004-08-10 | 2007-05-14 | 인사이트 산 디에고 인코포레이티드 | Amido compounds and their use as pharmaceuticals |
GEP20125565B (en) * | 2004-11-10 | 2012-07-10 | Incyte Corp | Lactam compounds and their pharmaceutical use |
US8110581B2 (en) * | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
BRPI0518281A2 (en) * | 2004-11-18 | 2008-11-18 | Incyte Corp | 11-beta hydroxylesterase dehydrogenase type i inhibitors and methods of using them |
FR2883285B1 (en) * | 2005-03-17 | 2007-05-18 | Sanofi Aventis Sa | 7- (2- (4- (3-TRIFLUOROMETHYL-PHENYL) -1,2,3,6-TETRAHUDRO-PYRID-1-YL) ETHYL) ISOQUINOLINE BESYLATE SALT, ITS PREPARATION AND USE IN THERAPEUTICS |
JP4864342B2 (en) * | 2005-04-27 | 2012-02-01 | 北興化学工業株式会社 | Method for producing biaryl compound |
JP2009508963A (en) * | 2005-09-21 | 2009-03-05 | インサイト・コーポレイション | Amide compounds and their use as pharmaceutical compositions |
CA2630492C (en) * | 2005-12-05 | 2015-04-14 | Incyte Corporation | Spiro-lactam compounds |
WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
KR20080091503A (en) * | 2006-01-31 | 2008-10-13 | 인사이트 코포레이션 | Amido compounds and their use as pharmaceuticals |
US20070213311A1 (en) * | 2006-03-02 | 2007-09-13 | Yun-Long Li | Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
JP2009535420A (en) * | 2006-05-01 | 2009-10-01 | インサイト・コーポレイション | Tetra-substituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
US7838544B2 (en) * | 2006-05-17 | 2010-11-23 | Incyte Corporation | Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same |
CL2008001839A1 (en) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compounds derived from 2,7-diazaspirocycles, inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1; pharmaceutical composition comprising said compounds; Useful to treat obesity, diabetes, glucose intolerance, type II diabetes, among other diseases. |
KR20100135711A (en) | 2007-12-20 | 2010-12-27 | 엔비보 파마슈티칼즈, 인코퍼레이티드 | Tetrasubstituted benzenes |
WO2011089072A1 (en) * | 2010-01-19 | 2011-07-28 | Bayer Cropscience Ag | Method for producing aryl and heteroarylacetic acid derivatives |
WO2018195649A1 (en) * | 2017-04-26 | 2018-11-01 | Alberta Research Chemicals Inc. | Substituted tetrahydropyridine derivatives as ido-1 inhibitors and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0398578B1 (en) * | 1989-05-17 | 1997-03-12 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as antiischemic agents |
FR2650505B1 (en) * | 1989-08-07 | 1994-06-03 | Midy Spa | USE OF TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES FOR THE PREPARATION OF MEDICINES FOR COMBATING INTESTINAL MOTORITY DISORDERS |
FR2662355B1 (en) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS. |
HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
DE4325855A1 (en) * | 1993-08-02 | 1995-02-09 | Boehringer Ingelheim Kg | Novel benzoic acid derivatives, processes for their preparation and their use as medicaments |
-
1995
- 1995-06-28 FR FR9507760A patent/FR2736053B1/en not_active Expired - Fee Related
-
1996
- 1996-06-26 ES ES96924023T patent/ES2183965T3/en not_active Expired - Lifetime
- 1996-06-26 EP EP02006482A patent/EP1216996A3/en not_active Withdrawn
- 1996-06-26 RU RU98101492/04A patent/RU2163237C2/en not_active IP Right Cessation
- 1996-06-26 PL PL96324216A patent/PL187087B1/en not_active IP Right Cessation
- 1996-06-26 HU HU9900055A patent/HUP9900055A3/en unknown
- 1996-06-26 IL IL12215996A patent/IL122159A/en not_active IP Right Cessation
- 1996-06-26 DE DE69623631T patent/DE69623631T2/en not_active Expired - Fee Related
- 1996-06-26 KR KR1019970709747A patent/KR100460581B1/en not_active IP Right Cessation
- 1996-06-26 EP EP96924023A patent/EP0837848B1/en not_active Expired - Lifetime
- 1996-06-26 PT PT96924023T patent/PT837848E/en unknown
- 1996-06-26 SK SK593-2003A patent/SK285433B6/en unknown
- 1996-06-26 SK SK1781-97A patent/SK283707B6/en unknown
- 1996-06-26 US US08/973,712 patent/US5981754A/en not_active Expired - Fee Related
- 1996-06-26 CA CA002225746A patent/CA2225746C/en not_active Expired - Fee Related
- 1996-06-26 CZ CZ19974222A patent/CZ291075B6/en not_active IP Right Cessation
- 1996-06-26 DK DK96924023T patent/DK0837848T3/en active
- 1996-06-26 EE EE9700348A patent/EE03870B1/en not_active IP Right Cessation
- 1996-06-26 PL PL357052A patent/PL192353B1/en not_active IP Right Cessation
- 1996-06-26 NZ NZ312723A patent/NZ312723A/en unknown
- 1996-06-26 BR BR9608662A patent/BR9608662A/en not_active IP Right Cessation
- 1996-06-26 UA UA97126360A patent/UA62914C2/en unknown
- 1996-06-26 AU AU64619/96A patent/AU715090B2/en not_active Ceased
- 1996-06-26 JP JP50420697A patent/JP3147906B2/en not_active Expired - Fee Related
- 1996-06-26 WO PCT/FR1996/000995 patent/WO1997001536A1/en active IP Right Grant
- 1996-06-26 TR TR97/01710T patent/TR199701710T1/en unknown
- 1996-06-26 AT AT96924023T patent/ATE223897T1/en not_active IP Right Cessation
- 1996-06-26 CN CNB961950900A patent/CN1153765C/en not_active Expired - Fee Related
- 1996-06-28 ZA ZA965527A patent/ZA965527B/en unknown
-
1997
- 1997-12-23 IS IS4641A patent/IS1999B/en unknown
- 1997-12-23 NO NO19976079A patent/NO310144B1/en unknown
-
1999
- 1999-01-14 HK HK99100183A patent/HK1014952A1/en not_active IP Right Cessation
-
2000
- 2000-07-31 JP JP2000231069A patent/JP3302351B2/en not_active Expired - Fee Related
-
2003
- 2003-01-15 CY CY0300004A patent/CY2312B1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4641A (en) | 4-Aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridine having neuromuscular and neurotransmitter activity | |
GR3029408T3 (en) | Novel piperidine derivatives, useful as neurokinin receptor antagonists | |
IL115572A0 (en) | Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them | |
NO914218L (en) | SYNERGISTIC ULTRAPHIOLETTABSORBER MIXTURES CONTAINING HYDRO-HYDROXYARYLTRIAZINES AND TETRAALKYL PIPERIDINES | |
AU3443595A (en) | Benzylpiperidine derivatives | |
DK0958280T3 (en) | Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceutical agents containing them | |
UA41928C2 (en) | Derivatives of oxAzolidine, a process for the preparation thereof, a pharmaceutical composition and a process for the preparation thereof, a method for the treatment of diseaseS | |
IL116387A (en) | 5-acyl-1,4-dihydropyridines for control of disorders of CNS with modulating action on potassium channels certain such novel compounds and their preparation | |
DE69701301D1 (en) | Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions | |
CA2275353A1 (en) | 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease | |
MX9801493A (en) | Fluorobutene acid amides. |